Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000062

Chief Medical Officer acquired 5,017 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2024-12-11 Option exercise +5,017 $0.54 $2,709 146,008 D
Derivatives
Rodman David Malcom Chief Medical Officer 2024-12-11 Option exercise · Stock Option −5,017 5,018 D
Loading xslF345X05/wk-form4_1734125816.xml…